News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
04 13 2021 10 studies highlight Quest Diagnostics' commitment to specialty genetics testing and research in areas such as mitochondrial mtDNA analysis and next generation sequencingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Blueprint Genetics announced today that they will present results of 10 studies at the virtual...
-
04 07 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2021 financial results on Thursday, April...
-
04 01 2021 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading...
-
03 15 2021 Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
-
03 11 2021 - Company to repurchase $900 million of its shares in first half of 2021At a virtual meeting with analysts and investors at its Investor Day, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of...